Clinical Trials Browser

Interventional × Brain Neoplasms × Immunotherapy × Clear all

Brain Neoplasms, Glioblastoma

NCT04650490 2023-03-02

STICk-IM-NSCLC

Phase 2 Withdrawn

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT04291092 2021-09-10

Camrelizumab Combined With Local Treatment in NSCLC Patients With BM

Phase 2 Unknown

63 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02197169 2018-07-16

Brain Neoplasms, Central Nervous System Diseases, Glioblastoma, Glioma, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Glandular and Epithelial, Neoplasms, Nerve Tissue, Nervous System Diseases, Central Nervous System Neoplasms, Neuroectodermal Tumors, Neoplasms, Neuroepithelial, Gliosarcoma

Clinical Trials

Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma

STICk-IM-NSCLC

Camrelizumab Combined With Local Treatment in NSCLC Patients With BM

TARGET-I